News & Updates

TNFα antagonists, non-TNF biologics both safe for treating IBD in cancer patients

20 Jan 2023

Tumour necrosis factor (TNF)-α antagonists show comparable safety as non-TNF biologics in the treatment of inflammatory bowel disease (IBD) in patients with active or recent cancer, as shown in a study.

TNFα antagonists, non-TNF biologics both safe for treating IBD in cancer patients

20 Jan 2023

It’s time to do away with neutropenic diet post-HSCT – experts

17 Jan 2023 by

Adopting a low-microbial, protective (neutropenic) diet offers no clear benefit to patients following hematopoietic stem cell transplantation (HSCT) in a study described as the first to investigate the role of neutropenic diet post-HSCT.

It’s time to do away with neutropenic diet post-HSCT – experts

17 Jan 2023

PPI exposure during early pregnancy poses no excess risk of congenital malformations

15 Jan 2023

The use of proton pump inhibitors (PPIs) during early pregnancy does not appear to put infants at increased risk of congenital malformations, as reported in a study. However, there seems to be a small risk increase for major congenital malformations and congenital heart defects.

PPI exposure during early pregnancy poses no excess risk of congenital malformations

15 Jan 2023

Elevated homocysteine level tied to higher NAFLD risk

14 Jan 2023

Circulating homocysteine and folate concentrations appear to play a significant role in the development of nonalcoholic fatty liver disease (NAFLD), a study has shown.

Elevated homocysteine level tied to higher NAFLD risk

14 Jan 2023

Ritlecitinib, brepocitinib superior to placebo for inducing remission in UC

13 Jan 2023

Ritlecitinib and brepocitinib as induction therapies for ulcerative colitis (UC) appear to be more effective than placebo while having an acceptable short-term safety profile, according to the results of a phase IIb study.

Ritlecitinib, brepocitinib superior to placebo for inducing remission in UC

13 Jan 2023

'Dysphagia cup' encourages older people to drink more

13 Jan 2023 by

An ergonomic, spill-proof cup that regulates the flow rate and reduce patients’ head tilt when drinking effectively reduces aspiration risk and increases fluid intake among its older adult users.

'Dysphagia cup' encourages older people to drink more

13 Jan 2023

JAK inhibitors pose increased risk of developing shingles

12 Jan 2023

Exposure to the Janus kinase (JAK) inhibitors tofacitinib and upadacitinib, as well as to JAK inhibitors as a class, appears to put individuals at increased risk of developing herpes zoster infection, with the risk increasing at higher doses, as reported in a study.

JAK inhibitors pose increased risk of developing shingles

12 Jan 2023

NAFLD screening a cost-effective approach among T2DM patients in SG

12 Jan 2023 by

Nonalcoholic fatty liver disease (NAFLD) screening strategies, particularly vibration-controlled transient elastography (VCTE) and fibrosis-4 (FIB-4), are a cost-effective approach to reduce disease burden among type 2 diabetes mellitus (T2DM) patients in Singapore, according to a study.

NAFLD screening a cost-effective approach among T2DM patients in SG

12 Jan 2023

Six-food elimination diet improves symptoms of eosinophilic esophagitis

12 Jan 2023

Dietary elimination with specific food trigger identification may be used in place of medical therapy for the treatment of adults with eosinophilic esophagitis (EoE), an immune-mediated inflammatory condition with tissue eosinophilia resulting in esophageal dysfunction, suggests a study.

Six-food elimination diet improves symptoms of eosinophilic esophagitis

12 Jan 2023

Recent hyperglycaemia helps detect pancreatic cancer early

11 Jan 2023

Pancreatic cancer may be identified early if assessment will be steered towards the point of recent hyperglycaemia based on elevated HbA1c, suggests a retrospective cohort study, noting that such early detection may then improve survival in cancer patients.

Recent hyperglycaemia helps detect pancreatic cancer early

11 Jan 2023

News & Updates

Filter by Specialty:

Specialty:

TNFα antagonists, non-TNF biologics both safe for treating IBD in cancer patients

TNFα antagonists, non-TNF biologics both safe for treating IBD in cancer patients

It’s time to do away with neutropenic diet post-HSCT – experts

It’s time to do away with neutropenic diet post-HSCT – experts

PPI exposure during early pregnancy poses no excess risk of congenital malformations

PPI exposure during early pregnancy poses no excess risk of congenital malformations

Elevated homocysteine level tied to higher NAFLD risk

Elevated homocysteine level tied to higher NAFLD risk

Ritlecitinib, brepocitinib superior to placebo for inducing remission in UC

Ritlecitinib, brepocitinib superior to placebo for inducing remission in UC

'Dysphagia cup' encourages older people to drink more

'Dysphagia cup' encourages older people to drink more

JAK inhibitors pose increased risk of developing shingles

JAK inhibitors pose increased risk of developing shingles

NAFLD screening a cost-effective approach among T2DM patients in SG

NAFLD screening a cost-effective approach among T2DM patients in SG

Six-food elimination diet improves symptoms of eosinophilic esophagitis

Six-food elimination diet improves symptoms of eosinophilic esophagitis

Recent hyperglycaemia helps detect pancreatic cancer early

Recent hyperglycaemia helps detect pancreatic cancer early